Director Jay K. Kunkel granted 12,331 units at Varex Imaging (VREX)

Rhea-AI Filing Summary

Varex Imaging Corp director Jay K. Kunkel received a grant of 12,331 Deferred Stock Units on February 12, 2026. The grant is recorded at a price of $0 per unit and is reported as directly owned.

Each Deferred Stock Unit converts into one share of Varex common stock. The units vest 100% on the earlier of one year from the grant date or the next annual stockholder meeting after the grant. Vested shares are delivered on the earlier of the third anniversary of the grant, a change in control, or Kunkel’s termination of service for any reason.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kunkel Jay K.

(Last) (First) (Middle)

C/O VAREX IMAGING CORP

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UT 84104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/12/2026		A		12,331		(2)	(2)	Common Stock	12,331	$0	12,331	D

Explanation of Responses:

1. Each Deferred Stock Unit converts into common stock on a one-for-one basis.

2. These Deferred Stock Units vest 100% on the earlier of (i) the one-year anniversary of the date of the grant and (ii) the next annual meeting of stockholders that occurs after the date of grant. Vested shares will be delivered to the reporting person upon the earlier of (i) the third anniversary of the date of grant (ii) a change in control or (iii) the reporting person's termination of service for any reason.

Remarks:

	/s/ Jay K. Kunkel	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Varex Imaging Corp (VREX) report for Jay K. Kunkel?

Varex Imaging Corp reported that director Jay K. Kunkel received 12,331 Deferred Stock Units on February 12, 2026. These units were granted at a stated price of $0 per unit and are held as directly owned derivative securities.

How do Jay K. Kunkel’s Deferred Stock Units at Varex Imaging Corp (VREX) convert to shares?

Each Deferred Stock Unit granted to Jay K. Kunkel converts into one share of Varex Imaging Corp common stock. The Form 4 specifies a one-for-one conversion ratio between Deferred Stock Units and underlying common shares when they are ultimately settled.

When do Jay K. Kunkel’s Deferred Stock Units at VREX vest?

The Deferred Stock Units vest 100% on the earlier of the one-year anniversary of the February 12, 2026 grant date or the next annual meeting of stockholders after the grant. This schedule fully vests the award at whichever of these corporate milestones occurs first.

When will shares from Jay K. Kunkel’s Varex (VREX) Deferred Stock Units be delivered?

Vested shares from the Deferred Stock Units will be delivered upon the earlier of the third anniversary of the grant date, a change in control, or Jay K. Kunkel’s termination of service. These conditions govern when the underlying Varex common stock is actually issued.

Is Jay K. Kunkel’s February 2026 Varex (VREX) transaction an open-market stock purchase?

No, the transaction is reported as a grant of 12,331 Deferred Stock Units with a transaction code indicating an award or other acquisition. It is a compensatory derivative award, not an open-market buy or sell of Varex Imaging Corp common stock.